Skip to Main Content

About The Controlled Substance Program for Research

The UCLA Controlled Substance Program for Research provides assistance and monitoring for the use of regulated drugs and precursors chemicals in research. 

Researcher registrations are not like practitioner registrations and are not automatically approved for Sch. 2-5, each research registration can only be approved for the specific materials and the associated schedules listed on the registration.

The following is a list of departments or units that we have established DEA Registrations and associated user authorizations. This list does not cover Schedule I material activities. For information about Schedule I registrations https://ehs.ucla.edu/individual-dea-registrations-researchers

Anesthesiology and Perioperative Medicine

Bio Engineering       

Biological Chemistry 

Dentistry

Head and Neck Surgery

Human Genetics        

IBP- Integrative Biology & Physiology 

Medicine- Cardiology      

Medicine- Dermatology

Medicine- Endocrinology

Medicine- Hematology and Oncology

Medicine- Infectious Disease

Medicine- NanoMedicine

Medicine- Pulmonary Disease & Critical Care

MIMG- Microbiology, Immunology & Molecular Genetics

Molecular & Medical Pharmacology

Neurobiology

Neurology

Nursing

Ophthalmology

Orthopedic Surgery

Pathology & Laboratory Medicine

Physics & Astronomy

Psychiatry and Biobehavioral Science

Psychology

Radiation Oncology

Radiological Sciences

Surgery

Urology

Pending registrations:
Chemistry & Biochemistry
Pediatrics
Mechanical & Aerospace Engineering
 

  • Manage Departmental DEA license for Research and their associated use authorizations
  • Inventory management from procurement to disposal 
  • Document management (standardization and centralization)
  • Conduct audits, inspections, and biennial inventories
  • Investigate and report suspected diversion, excessive loss, spills, or theft
  • Liaison for regulatory agencies 
  • Provide guidance on regulatory and policy requirements
  • Precursors, List 1 and 2 chemicals procurement document review 
  • Dangerous Drug and Device procurement and disposal services for DGSOM

Our program does not cover activities conducted under:

Individual DEA Registrants 
Individual registrants must comply with the activities listed under their individual registration and are responsible for proper purchasing, recordkeeping, disposal, and other regulated practices

Schedule I DEA Registrants
Schedule I registrants must be associated with a specific principal investigator and can not be for a department as a result researchers must apply and maintain an individual registration for their schedule I activities.

Patient- Care setting
Patient care activities are outside the scope of a research registration and are covered by a UC health system, veterinary teaching hospital, pharmacy, or clinic and associated practitioners. This includes patient care activities involving a human subject.

Non UCLA locations
A DEA registration is associated with a specific location in which the material must be stored. When performing research at a non-University of California facility, UC researchers will be subject to the host institution’s controlled substances policies. Researchers may need to register independently for an individual DEA registration.

Dangerous Drugs and/or Devices and DEA-exempt chemical preparations- with the exception of DGSOM
Dangerous Drugs and/or Devices (prescription drugs) may be ordered without a prescription as defined by California Business and Professions Code Chapter 9, Division 2, Article 3 §4059 and §4059.5 by authorized Individuals, working in a research laboratory conducting authorized University activities with the use of Dangerous Drugs and/or Devices. Researchers are responsible for procuring, maintaining security of, keeping records for, and disposing of Dangerous Drugs and/or Devices in accordance with federal and state regulations.

 A researcher need not obtain a DEA registration to purchase and use DEA-exempt chemical preparations that meet the requirements of 21 C.F.R. §1308.24 and as listed Exempt Chemical Preparations List published by DEA’s Diversion Control Division.

Field work- must be reviewed on an individual basis
Prior approvals and import/export license may be required to transport material to a remote location. Controlled substance must never be transported out side of approved locations. Possession of controlled substances without approvals from the DEA may result in fines and legal ramifications.